Boston Scientific claims UK court win v Edwards

Boston Scientific Corporation said the UK Court of Appeal “dismissed Edwards Lifesciences’ appeal and upheld a prior court decision that Edwards’ Sapien 3 device infringes Boston Scientific patent EP (UK) 2 926 766 and that all claims of that patent are valid.”

Separately, Boston Scientific said it plans to appeal the US Patent Office’s recent Inter Partes Review finding that certain claims of the Boston Scientific US patent 8,992,608 asserted against Edwards are invalid.

Desiree Ralls-Morrison, general counsel, Boston Scientific, said: “We are pleased with another positive ruling from the European courts which further substantiates our intellectual property.

“We see the U.K. court’s decision as an important validation of our patents and supports our goal to bring differentiated solutions to patients suffering from severe and symptomatic aortic valve stenosis.”